STIMFORTE

NEW MEDICAMENT FOR CORRECTION
OF IMMUNE PROTECTION
OF THE HUMAN ORGANISM

DEVELOPMENT OF INNOVATIVE MEDICAMENTS
Currently, there is a significant increase in acute and chronic infectious diseases of a bacterial, fungal, protozoal, viral nature in the world. The etiological factor of these diseases is often conditional-pathogenic or opportunistic microbes with atypical biological properties, which have multiple antibiotic resistance. Dangerous viral diseases such as Dengue fever, Crimean hemorrhagic fever, Ebola fever and others are spreading more and more.

Against the background of reduced immunity, even the use of highly effective antibiotics of the latest generation does not always give a good clinical effect, but on the contrary, can cause a further decrease in immunity. The creation of vaccines is also not a panacea, since many strains of variable viruses are not blocked by vaccines.

It became obvious that it is almost impossible to fight against many infectious diseases without increasing immunity. Means are needed that help to cope with the most important problem of reducing immunity and help restoring the protective functions of the body. Such a drug is STIMFORTE®.

 MECHANISM OF ACTION AND MEDICAMENT PROPERTIES 

– STIMFORTE® is able to stimulate innate immunity through pathogen-recognized receptors TLR4 and NOD2. It is the first such medicament, which isnot associated with the products of microorganisms.The medicament is non-immunogenic, has manifest adjuvantproperties, that is, it can significantly enhance the recognition and «remembering» of a pathogen by the immune system, which is especially important for the treatment of chronic diseases.
– STIMFORTE® stimulates the proliferation and differentiation of spleen promyelocytes.
– STIMFORTE® significantly activates natural and toxic killers, macrophages and dendritic cells.
– STIMFORTE® enhances both specific and non-specific antiviral immunity.
– STIMFORTE® is the only natural origin medicament based on glycosaminoglycans.

STIMFORTE EFFICIENCY

STIMFORTE® is an immunostimulant with proven treatment effectiveness:
— genital herpes;
— recurrent furunculosis;
— chronic viral hepatitis B (in the acute stage);
— acute hepatitis B (moderate severity forms).


 HERPES TREATMENT 

The use of the medicament STIMFORTE® in the treatment of genital herpes in patients complex therapy significantly reduces:
— frequency
— duration
— the severity of subsequent relapses

 HEPATITIS TREATMENT 

The use of STIMFORTE® in the treatment of moderate hepatitis B (HBV):
— interferes with the chronicity of the disease;
— reduces the time of intoxication of patients with acute viral hepatitis B;
— contributes to a more rapid normalization of the general condition of patients, increase their activity and restore performance;
— leads to a more rapid decrease in the manifestations of the cytolytic syndrome;
— shows high therapeutic efficacy.

The use of STIMFORTE® in the treatment of chronic viral hepatitis B in the acute stage:
— causes prolonged biochemical remission of patients with chronic hepatitis B;
— reduces the time to restore the immune status and functional activity of IFN;
— leads to a sharp decrease of the HBV virus titer up to undetectable values;
— leads to a more rapid decrease in the manifestations of the cytolytic syndrome;

 TREATMENT OF FURUNCULOSIS 

The use of STIMFORTE® in the treatment of furunculosis:
— reduces the duration and severity of subsequent relapses;
— helps to reduce the duration of antibiotic therapy and the duration of bed days;
— significantly enhances the therapeutic effect when combined with antibacterial .medicaments.